Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Ivabradine and the SIGNIFY conundrum
Author: Beltrame, J.
Citation: European Heart Journal, 2015; 36(46):3297-3299
Publisher: Oxford University Press
Issue Date: 2015
ISSN: 0195-668X
Statement of
John F. Beltrame
Abstract: This editorial refers to ‘Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: the SIGNIFY study’, by K.M. Fox et al., on page doi:10.1093/eurheartj/XXX Stable angina is a prevalent and disabling condition that occurs in 10–14% of those aged 65–84 years,1 with population studies suggesting that almost a third of affected patients experience an angina episode at least once a week.2 Treatment focuses upon the alleviation of angina symptoms and the prevention of cardiac events. Although the development of cardioprotective agents has received considerable attention in recent years, there has been less progress with novel antianginal agents.
Keywords: Humans; Heart Rate; Coronary Artery Disease
Description: Editorial
Rights: © The Author 2015. For permissions please email:
RMID: 0030032823
DOI: 10.1093/eurheartj/ehv368
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.